Mucosal vaccine adjuvants containing bacterial flegellins as an active component
The present invention relates to mucosal vaccine adjuvants containing flagellins, the structural component of flagella, originated from Vibrio vulnificus, Salmonella typhimurium, and Listeria monocytogenes as an active component.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
07.02.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to mucosal vaccine adjuvants containing flagellins, the structural component of flagella, originated from Vibrio vulnificus, Salmonella typhimurium, and Listeria monocytogenes as an active component. |
---|---|
Bibliography: | Application Number: CN200580002321 |